Literature DB >> 22285844

Extended pelvic resections for recurrent or persistent uterine and cervical malignancies: an update on out of the box surgery.

V Andikyan1, F Khoury-Collado, Y Sonoda, S R Gerst, K M Alektiar, J S Sandhu, B H Bochner, R R Barakat, P J Boland, D S Chi.   

Abstract

OBJECTIVE: To update our report on the outcome of patients who underwent extended pelvic resection (EPR) for recurrent or persistent uterine and cervical malignancies.
METHODS: We reviewed the records of all patients who underwent EPR between 6/2000 and 07/2011. EPR was defined as an en-bloc resection of a pelvic tumor with sidewall muscle, bone, major nerve, and/or major vascular structure. Complications up to 180 days post surgery were analyzed. Survivals were estimated using the Kaplan-Meier method.
RESULTS: We identified 22 patients. Median age at the time of EPR was 58 years (range, 36-74). Median tumor diameter was 5.4 cm (range, 1.5-11.2). Primary tumor sites included: uterus, 13; cervix, 7; synchronous uterus/cervix, 1; and synchronous uterus/ovary, 1. The EPR structures were: muscle, 13; nerve, 10; bone, 8; vessel, 5. Complete gross resection with microscopically negative margins (R0 resection) was achieved in 17 patients (77%). There were no perioperative mortalities. Major postoperative complications occurred in 14 patients (64%). The two most common morbidities were pelvic abscesses and peripheral neuropathies. Median follow-up time was 28 months (range, 6-99). The 5-year overall survival (OS) for the entire cohort was 34% (95% CI, 13-57). For the 17 patients who had an R0 resection, the 5-year OS was 48% (95% CI, 19-73). In patients with positive pathologic margins (n=5), the 5-year OS was 0%.
CONCLUSION: EPR was associated with prolonged survival when an R0 resection was achieved. The high rate of postoperative complications remains a hallmark of these procedures and properly selected patients should be extensively counseled preoperatively.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22285844     DOI: 10.1016/j.ygyno.2012.01.031

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  7 in total

1.  Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

Authors:  Olivio F Donati; Yulia Lakhman; Evis Sala; Irene A Burger; Hebert A Vargas; Debra A Goldman; Vaagn Andikyan; Kay J Park; Dennis S Chi; Hedvig Hricak
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

Review 2.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

3.  Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Authors:  Giuseppe Vizzielli; Lucia Tortorella; Carmine Conte; Vito Chiantera; Valerio Gallotta; Nazario Foschi; Martina Arcieri; Gabriella Ferrandina; Anna Fagotti; Filiberto Zattoni; Giovanni Scambia; Alfredo Ercoli
Journal:  Ann Surg Oncol       Date:  2020-10-15       Impact factor: 5.344

4.  A post-recurrence survival-predicting indicator for cervical cancer from the analysis of 165 patients who developed recurrence.

Authors:  Kosuke Yoshida; Hiroaki Kajiyama; Fumi Utsumi; Kaoru Niimi; Jun Sakata; Shiro Suzuki; Kiyosumi Shibata; Fumitaka Kikkawa
Journal:  Mol Clin Oncol       Date:  2017-12-08

5.  Outcomes of Ureteroneocystostomy in Patients With Cancer.

Authors:  Gillian L Stearns; Amy L Tin; Nicole E Benfante; Daniel D Sjoberg; Jaspreet S Sandhu
Journal:  Urology       Date:  2021-09-06       Impact factor: 2.633

Review 6.  The role of imaging in pelvic exenteration for gynecological cancers.

Authors:  Pamela Ines Causa Andrieu; Sungmin Woo; Eric Rios-Doria; Yukio Sonoda; Soleen Ghafoor
Journal:  Br J Radiol       Date:  2021-05-07       Impact factor: 3.629

7.  Selection of Treatment Regimens for Recurrent Cervical Cancer.

Authors:  Xiaopei Chao; Xiaochen Song; Huanwen Wu; Yan You; Ming Wu; Lei Li
Journal:  Front Oncol       Date:  2021-02-02       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.